Skip to content
value.today

Via Science, Inc.

Total raised
$47 M
4 rounds on record
Latest round
$28 M
Jan 2025
First round on record
May 2019
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Via Science, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jan 2025$28 MNo. 4$10 to $50 million

Via Science, Inc.: Raise no. 4, Jan 2025

Investors in this round

13 investors had bought by the notice of Mar 4, 2025: 13 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$28 M of $28 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Colin Gounden · Executive Officer, Director
  • Katherine Ravanis · Executive Officer
  • Adam Jackson · Director
  • Alan Parnass · Director
  • Danny Cotter · Director
  • Kasper Sage · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Colin Gounden, Ceo. Source: SEC Form D, newest notice filed Mar 4, 2025. Read the notice at the SEC.

equity, optionsSEC
Mar 2021$10 MNo. 3$10 to $50 million

Via Science, Inc.: Raise no. 3, Mar 2021

Investors in this round

7 investors had bought by the notice of Feb 18, 2022: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $13 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Colin Gounden · Executive Officer, Director
  • Katherine Ravanis · Executive Officer
  • Danny Cotter · Director
  • Duncan McFarland · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Colin Gounden, Chief Executive Officer. Source: SEC Form D and 1 amendment, newest notice filed Feb 18, 2022. Read the notice at the SEC.

equitySEC
Dec 2019$3 MNo. 2$2 to $10 million

Via Science, Inc.: Raise no. 2, Dec 2019

Investors in this round

3 investors had bought by the notice of Apr 29, 2020: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, debt
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Colin Gounden · Executive Officer, Director · Chief Executive Officer, President, Treasurer and Director
  • Jeremy Taylor · Executive Officer · Chief Scientific Officer
  • Katherine Ravanis · Executive Officer · Chief Operating Officer and Secretary
  • Danny Cotter · Director · Director
  • Duncan McFarland · Director · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Colin Gounden, CEO and President. Source: SEC Form D and 1 amendment, newest notice filed Apr 29, 2020. Read the notice at the SEC.

equity, debtSEC
May 2019$6 MNo. 1$2 to $10 million

Via Science, Inc.: Raise no. 1, May 2019

Investors in this round

3 investors had bought by the notice of Jun 13, 2019: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $7 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Colin Gounden · Executive Officer, Director · Chief Executive Officer, President and Director
  • Katherine Ravanis · Executive Officer · Chief Operating Officer, Treasurer and Secretary
  • Kristen Merrill · Executive Officer · Vice President
  • Danny Cotter · Director
  • Duncan McFarland · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Item 13(b) includes Convertible Notes totaling $3,948.427.45 that were converted into shares.”

Signed by Colin Gounden, CEO and President. Source: SEC Form D, newest notice filed Jun 13, 2019. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Via Science, Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2025).

    SEC Form D · Mar 2025

  • The industry group it chose in its notices: Other Technology.

    SEC Form D · Mar 2025

That is all the official record says: Via Science, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Via Science, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 13 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Via Science, Inc.
NameRoleNamed in
Colin GoundenExecutive officerMar 2025
Katherine RavanisExecutive officerMar 2025
Jeremy TaylorChief Scientific OfficerApr 2020
Kristen MerrillVice PresidentJun 2019
Adam JacksonDirectorMar 2025
Alan ParnassDirectorMar 2025
Colin GoundenDirectorMar 2025
Danny CotterDirectorMar 2025
Kasper SageDirectorMar 2025
Duncan McFarlandDirectorFeb 2022